Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M D Kitzis

Showing results (31-40 of 87) with videos related to

Pageof 9
Sort By:
The Journal of Antimicrobial Chemotherapy|August 1, 1989
Tigemonam activity against clinical isolates of Enterobacteriaceae and Enterobacteriaceae with known mechanisms of resistance to beta-lactam antibioticsF Nélet, L Gutmann, M D Kitzis, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1986
Comparative evaluation of a new beta-lactamase inhibitor, YTR 830, combined with different beta-lactam antibiotics against bacteria harboring known beta-lactamasesL Gutmann, M D Kitzis, S Yamabe, et al.
The Journal of Antimicrobial Chemotherapy|April 1, 1993
Activity of the beta-lactamase inhibitor BRL 42715 against cephalosporinases produced by EnterobacteriaceaeX Y Zhou, M D Kitzis, J F Acar, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 1995
SYN987, SYN1193, and SYN1253, new quinolones highly active against gram-positive cocciM D Kitzis, F W Goldstein, N Ishida, et al.
Annales De Microbiologie|March 1, 1983
[Activity of sulbactam and clavulanic acid, alone and combined, on Acinetobacter calcoaceticus]M D Kitzis, F W Goldstein, R Labia, et al.
The Journal of Antimicrobial Chemotherapy|July 15, 1999
In-vitro activity of levofloxacin, a new fluoroquinolone: evaluation against Haemophilus influenzae and Moraxella catarrhalisM D Kitzis, F W Goldstein, M Miegi, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 1983
Activity of imipenem on aerobic bacteriaJ F Acar, F W Goldstein, M D Kitzis, et al.
The Journal of Antimicrobial Chemotherapy|January 1, 1990
In-vitro activity of azithromycin against various Gram-negative bacilli and anaerobic bacteriaM D Kitzis, F W Goldstein, M Miégi, et al.
The Journal of Infectious Diseases|July 9, 1999
In vitro exchange of fluoroquinolone resistance determinants between Streptococcus pneumoniae and viridans streptococci and genomic organization of the parE-parC region in S. mitisC Janoir, I Podglajen, M D Kitzis, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1996
High-level fluoroquinolone resistance in Streptococcus pneumoniae requires mutations in parC and gyrAC Janoir, V Zeller, M D Kitzis, et al.
Pageof 9

Showing results (31-40 of 87) with videos related to

Sort By:
Pageof 9
The Journal of Antimicrobial Chemotherapy|August 1, 1989
Tigemonam activity against clinical isolates of Enterobacteriaceae and Enterobacteriaceae with known mechanisms of resistance to beta-lactam antibioticsF Nélet, L Gutmann, M D Kitzis, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1986
Comparative evaluation of a new beta-lactamase inhibitor, YTR 830, combined with different beta-lactam antibiotics against bacteria harboring known beta-lactamasesL Gutmann, M D Kitzis, S Yamabe, et al.
The Journal of Antimicrobial Chemotherapy|April 1, 1993
Activity of the beta-lactamase inhibitor BRL 42715 against cephalosporinases produced by EnterobacteriaceaeX Y Zhou, M D Kitzis, J F Acar, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 1995
SYN987, SYN1193, and SYN1253, new quinolones highly active against gram-positive cocciM D Kitzis, F W Goldstein, N Ishida, et al.
Annales De Microbiologie|March 1, 1983
[Activity of sulbactam and clavulanic acid, alone and combined, on Acinetobacter calcoaceticus]M D Kitzis, F W Goldstein, R Labia, et al.
The Journal of Antimicrobial Chemotherapy|July 15, 1999
In-vitro activity of levofloxacin, a new fluoroquinolone: evaluation against Haemophilus influenzae and Moraxella catarrhalisM D Kitzis, F W Goldstein, M Miegi, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 1983
Activity of imipenem on aerobic bacteriaJ F Acar, F W Goldstein, M D Kitzis, et al.
The Journal of Antimicrobial Chemotherapy|January 1, 1990
In-vitro activity of azithromycin against various Gram-negative bacilli and anaerobic bacteriaM D Kitzis, F W Goldstein, M Miégi, et al.
The Journal of Infectious Diseases|July 9, 1999
In vitro exchange of fluoroquinolone resistance determinants between Streptococcus pneumoniae and viridans streptococci and genomic organization of the parE-parC region in S. mitisC Janoir, I Podglajen, M D Kitzis, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1996
High-level fluoroquinolone resistance in Streptococcus pneumoniae requires mutations in parC and gyrAC Janoir, V Zeller, M D Kitzis, et al.
Pageof 9